Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562247 · ClinicalTrials.gov registry record · NA
Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT03562247 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 31 participants.
The verdict
NCT03562247, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Numerous studies show that remote monitoring and/or telenursing improves outcomes for patients especially those with chronic diseases. It is proposed that structured telenursing with non-invasive home monitoring of forced vital capacity and oxygen saturation in newly diagnosed patients with IPF will decrease hospitalizations for respiratory illness, increase compliance with therapies, and ultimately increase quality of life.
Interventions
- OTHER Usual Care of IPF
- OTHER Telenursing
- OTHER Telenursing and Remote Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-05-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03562247
The ClinicalTrials.gov registry entry for NCT03562247 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual Care of IPF is the first listed.
NCT03562247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03562247 about?
NCT03562247 is a clinical study titled "Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)". Numerous studies show that remote monitoring and/or telenursing improves outcomes for patients especially those with chronic diseases. It is proposed that structured telenursing with non-invasive home monitoring of forced vital capacity and oxygen saturation in newly diagnosed patients with IPF will...
What is the current status of trial NCT03562247?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2018-08-01. Estimated completion is 2020-05-26.
What interventions are being tested in trial NCT03562247?
The interventions under investigation include: Usual Care of IPF (OTHER), Telenursing (OTHER), Telenursing and Remote Monitoring (OTHER).
Who is sponsoring clinical trial NCT03562247?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.